Celcuity (NASDAQ:CELC – Get Free Report) is projected to issue its quarterly earnings data before the market opens on Wednesday, March 26th. Analysts expect the company to announce earnings of ($0.72) per share for the quarter. Parties that are interested in registering for the company’s conference call can do so using this link.
Celcuity Stock Performance
Shares of CELC opened at $10.84 on Tuesday. Celcuity has a 1 year low of $8.53 and a 1 year high of $22.19. The company has a debt-to-equity ratio of 0.65, a current ratio of 10.35 and a quick ratio of 10.36. The stock’s fifty day moving average price is $11.24 and its two-hundred day moving average price is $13.08. The firm has a market cap of $402.49 million, a PE ratio of -4.15 and a beta of 0.65.
Wall Street Analysts Forecast Growth
Separately, Needham & Company LLC boosted their price objective on Celcuity from $23.00 to $29.00 and gave the company a “buy” rating in a research note on Thursday, February 6th. Six research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Buy” and a consensus price target of $30.17.
About Celcuity
Celcuity Inc, a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment.
Read More
- Five stocks we like better than Celcuity
- 10 Best Airline Stocks to Buy
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- 3 Best Fintech Stocks for a Portfolio Boost
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- What is a Death Cross in Stocks?
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for Celcuity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celcuity and related companies with MarketBeat.com's FREE daily email newsletter.